2025: Tromboz, Gemostaz i Reologiya, Nr. 2 | Tromboz, Gemostaz I Reologiya

Review

Andrey P. Momot , Mikhail I. Neymark, Dmitry V. Fedorov, Lyudmila A. Strozenko, Lyudmila Р. Tsyvkina

11-21

The state of thrombotic readiness and its possible role in thrombosis realization in thrombophilia and/or with thrombogenic risk factors: 616.151.511-005.6

Irina A. Zolotovskaya, Maria E. Ramodina

44-52

Endothelial dysfunction in patients with chronic kidney disease: 616-06:616.61

Pavel G. Madonov, Svetlana V. Mishenina, Nataliya V. Kikhtenko, Eugene V. Roitman

53-65

Thrombolytic subtilisins: 615.273.55

Evgeniya V. Sсhreiner, Valeria I. Bystrova, Evgeny A. Pokushalov, Dmitry A. Kudlay

66-74

Omega‑3 polyunsaturated fatty acids in treatment and prevention of cardiovascular diseases: 616.1:615.272.4

Original papers

Lyudmila A. Strozenko, Andrey P. Momot, Lyudmila Р. Tsyvkina, Yuri F. Lobanov, Dmitry A. Momot, Viktor S. Ponomarev

22-31

Predictors of thrombotic complications in children with bleeding manifestations: 616.151.511-005.6-053.2-036

Vyacheslav М. Vdovin, Andrey P. Momot, Igor I. Shakhmatov, Mikhail I. Neymark, Natalia A. Lycheva, Dmitry A. Momot, Igor P. Bobrov

32-43

The intravenous administration importance of small doses of exogenous fibrin monomer to minimize post-traumatic blood loss in the experiment: 612.115.1-001.1-005.1-092.4

Evgeniy P. Izmailov , Irina V. Tkebuchava, Sergey S. Katkov, Rustem R. Saifullin

75-82

Prolonged mechanical ventilation via tracheostomy in patients with abdominal sepsis: 616.381:616.94-07-08:616.24-008.4:615.816.2:616.231-089.85

Minh D. Tran, Marina Kh. Shurdumova, Elizaveta A. Petrova, Evgeniya A. Koltsova, Albina N. Yasamanova, Georgiy G. Avakyan, Ivan A. Koltsov

83-94

Vascular-platelet hemostasis in hyperacute and acute phases of cardioembolic stroke during anticoagulant therapy: 612.115.35

Svetlana Yu. Timokhova, Aligeidar A. Ragimov , Sergey V. Sinkov, Sergey V. Grigoriev, Vladislav V. Golubtsov, Margarita Yu. Ananich

95-102

Restrictive strategy of transfusion therapy in the peripartum period: 616-035.1

Alexandra V. Guskova, Aleksandra A. Shalyova, Tatiana N. Subbotina, Svetlana V. Vereshchagina, Olga N. Yakimenko, Anna A. Chernova, Irina A. Suzdaleva

103-112

Study of thrombophilia genetic polymorphisms and hemostasis parameters in a group of young athletes: 575.174.015.3:616-005.6

Galina B. Kuchma, Uliana A. Yakubova, Liliya K. Kozlova, Genrietta G. Bagirova, Svetlana A. Lebedenko, Veronika V. Tatarinova, Tatyana A. Bashkatova, Polina A. Plotnikova

113-121

Hemophilia in the Orenburg region: analysis of mortality causes, 2008–2024: 616.151.514:314.14/470.56

Clinical cases

Nadezda A. Vorobyeva, Alyona I. Vorobyeva, Alexandra S. Vorontsova, Natalya V. Bykova

122-128

Perioperative management of a patient with hereditary hypoproconvertinemia: 612.116.2:616.151.5

Tatiana A. Andreeva, Olga E. Zalepukhinina, Olga A. Krasheninnikova, Victoriya A. Pozdnyakova, Victor Yu. Petrov

129-134

Clinical experience with lonoctocog alfa for prophylaxis in a patient with hemophilia A: 616-005.1:616.151.514-056.7